Enhabit Home Health & Hospice - EHAB Company Value to Revenue

Public company logo of ehab.com (EHAB)

Enhabit, Inc. (EHAB) management is currently fighting for shareholder trust due to declining service yields. The Enterprise Value to Sales ratio clearly confirms these challenges, where the 1094.91 parameter determines the metric's magnitude. Meanwhile, Enhabit, Inc. (EHAB) is implementing digital document management for environmental sustainability and developing partnerships with hospitals for joint home-based patient rehabilitation.

EHAB Enhabit: EV/Sales Multiple in the range 11/23/2025 - 05/30/2026

Enhabit Home Health & Hospice - analytical breakdowns and key metrics (EHAB)

- share price and consensus valuation forecast:
- money and cash flow information:
Fundamental company valuation:Enhabit, Inc. - EHAB
Product sample of Enhabit

Steady demand for hospice services and an aging population provide Enhabit, Inc. (EHAB) with predictable cash flows. This indicator compares the total enterprise value to annual revenue, excluding the impact of debt on the valuation. Low values signal that the asset is undervalued, while a sharp increase warns of overheating. It is critical for investors to distinguish a temporary correction from a degradation of the business model. The price action of the enterprise value-to-revenue multiple clearly confirms the fundamental stability of the company.